An Overview Of Mesothelioma Cancers
What are Mesothelioma Cancers?
Mesothelioma cancers are the cancers that spread in the mesothelium tissues. Mesothelium in general is the name of tissue that forms lining of different body organs such as heart, lungs, abdomen and reproductive organs. The lining around abdominal organs is known as peritoneal membrane. Lining around lungs is called pleural membrane while the lining around heart is called pericardium.
These linings perform two functions. They protect the internal organs by producing a lubricating fluid and to allow the smooth movement of the internal organs. Mesothelioma cancers are the cancers affecting these membranes. The names of the cancers depend on the tissue or linings they affect. Peritoneal mesothelioma, pleural mesothelioma and pericardial mesothelioma are the names of cancers of linings of abdomen, lungs and heart, respectively. Pleural mesothelioma is the most common of all mesothelioma cancers and is found in 70 % of the mesothelioma patients. Peritoneal mesothelioma constitutes 10% to 20% of the mesothelioma patients while third type pericardial mesothelioma, is rare.
Symptoms of Mesothelioma Cancers
Symptoms of mesothelioma cancers are same as of other common diseases. It makes diagnosis mesothelioma cancers a difficult task. Pain and swelling in abdomen, weakness, loss of weight, loss of appetite and nausea are some symptoms of peritoneal mesothelioma. Symptoms of pleural mesothelioma are persistent cough, difficulty in breathing, weight loss, loss of appetite, weakness, chest pains, lower back pains and difficulty in swallowing.
One alarming fact about the mesothelioma cancers is its extended latency period. These cancers may remain asymptomatic in the body for even up to 50 years. Chances of survival for mesothelioma patients are rare and the average survival period after diagnosis is not more than 12-24 months. Surgery if diagnosed early, chemotherapy and radiation therapy are some common treatments for all types of mesothelioma cancers.
0 comments:
Post a Comment